All Episodes

October 25, 2023 27 mins

In this podcast interview with Dr. Fred Grossman, President and Chief Medical Officer of Coya, the following key points were discussed:

- The podcast, "The Patients Speak," aims to bridge the gap between healthcare science and the patient perspective.

- Dr. Grossman highlighted the significant unmet needs in conditions like ALS and Alzheimer's disease, emphasizing the personal impact on patients and their families.

- ALS (Lou Gehrig's disease) is a rapidly progressive neurodegenerative disease that affects muscle function, speech, and respiration, with a high fatality rate.

- Alzheimer's disease is also a devastating condition, and patients and their families are eagerly seeking treatments.

- The discussion touched on the importance of considering patients' perspectives on daily activities, which are greatly affected by these conditions.

- Dr. Grossman emphasized the need for objective measures in clinical trials while acknowledging the importance of subjective input from patients and their families.

- Patients' altruism and desire to contribute to research were highlighted as essential drivers in clinical trials.

- Dr. Grossman discussed Coya's focus on regulatory T cells (Tregs) as a key cellular target in treating ALS due to their role in regulating inflammation.

- Coya's treatment, Coya 302, aims to increase the number and function of Tregs to stabilize the immune system and halt ALS progression.

- The potential impact of Coya 302 was discussed, with the aim of prolonging survival and improving patients' quality of life.

- Dr. Grossman mentioned that Coya is planning a large-scale study for Koya 302 with a potential start in six months.

- Collaboration with patient advocacy groups and the Healy Platform Trial was highlighted as a way to involve patients in research and speed up progress.

- The importance of clear and honest communication between patients and healthcare providers was emphasized, with patients having the right to know what to expect in their condition.

Fred's Website

BSB Media

Mark as Played

Advertise With Us

Popular Podcasts

Bookmarked by Reese's Book Club

Bookmarked by Reese's Book Club

Welcome to Bookmarked by Reese’s Book Club — the podcast where great stories, bold women, and irresistible conversations collide! Hosted by award-winning journalist Danielle Robay, each week new episodes balance thoughtful literary insight with the fervor of buzzy book trends, pop culture and more. Bookmarked brings together celebrities, tastemakers, influencers and authors from Reese's Book Club and beyond to share stories that transcend the page. Pull up a chair. You’re not just listening — you’re part of the conversation.

On Purpose with Jay Shetty

On Purpose with Jay Shetty

I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!

Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.